Please read and agree to the
terms and conditions
of this site.
I agree
/tech
Format
photo
Tags
biotech
boehringer ingelheim
clinical trials
eli lilly
empagliflozin
europe
europe blog main
europe top stories
fda
indiana blog main
indiana top stories
life sciences
national blog main
new york blog main
new york top stories
slgt2 inhibitor
type 1 diabetes
type 2 diabetes
What
approval
bid
boehringer
diabetes
drug
eli
expand
fallen
fda
ingelheim
lilly
marketed
medicine’s
patients
rejects
short
type
Language
unset
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
{{::tile.title}}